Letter to the Editor: Inquirer readers on billing by long-term care pharmacies
By Rob Franklin | Published December 11, 2025 in The Philadelphia Enquirer
Well-meaning policy
If you walk into any nursing home in the southeastern corner of the commonwealth, you’ll find a highly choreographed system of long-term care (LTC) pharmacies humming along that help keep older Pennsylvanians safe and are the backbone of patient care.
But this system is just months away from a potential collapse. Unless the Trump administration or Congress takes action now, on Jan. 1, a new policy will devastate LTC pharmacies that serve senior living facilities and nursing homes.
Passed during the Biden administration, the Inflation Reduction Act allowed the federal government to negotiate with drug companies to determine “maximum fair prices” on certain expensive brand-name drugs for Medicare Part D beneficiaries — a policy designed to help seniors afford medications.
But there’s a problem: The law is about to bankrupt the very pharmacies these seniors depend on to stay alive.
By setting “maximum fair prices” on certain brand-name drugs, the policy significantly reduces the reimbursement rates LTC pharmacies receive.
This price change will have rippling effects on all facilities that depend on the services of LTC pharmacies, including the 200,000 Medicare Part D beneficiaries over age 65 who have long-term care needs.
The Trump administration can act via an executive order to keep LTC pharmacies operational by delaying or modifying the new drug pricing until a sustainable payment model is identified.
Simultaneously, Congress must pass the bipartisan Preserving Patient Access to Long-Term Care Pharmacies Act (HR 5031). This legislation would establish a temporary $30 supply fee for each prescription filled under the new negotiated prices — a modest investment that would keep pharmacies solvent through 2027.
We can’t afford to look the other way — our seniors deserve a system that supports them, not one that collapses under the weight of well-meaning policy.
Read the full article on The Philadelphia Enquirer here
Recent Posts
-
CMS Releases RFI on Part D Pharmacy Contracting Standards
Yesterday, CMS released a new Request for Information (RFI) seeking input on how it should establish “reasonable and relevant” pharmacy contracting standards in Medicare Part D, as required by the Consolidated Appropriations Act, 2026 (CAA). The new standards will apply beginning in plan year 2029. Importantly for long-term care (LTC) pharmacy, the RFI specifically asks […]
-
Pharmacy Group Wants CMS To Distinguish LTCs From Retailers Through RFI
Lauren Brensel // Inside Health Policy – September 16, 2026 A trade association representing long-term care pharmacies (LTCs) is hoping CMS will use an upcoming request for information to establish guidance on contracting issues like reimbursement rates and network adequacy standards that could differ for retail pharmacies. The group has met with CMS to discuss […]
-
SCPC Submits Pre-Comment Letter on Medicare Part D Pharmacy Contracting Standards
SCPC submitted a pre-comment letter to CMS outlining key long-term care (LTC) pharmacy considerations as the agency prepares its Request for Information on “reasonable and relevant” Medicare Part D pharmacy contracting standards. The letter highlights LTC-specific issues related to reimbursement, network access, contracting practices, audits, beneficiary protections, and other Part D contracting challenges. Read SCPC’s […]
Stay Connected
Get the latest news and updates on issues impacting the long-term care pharmacy community.